A new paper published in New England Journal of Medicine details how an 18-year-old patient being treated at BC Children’s Hospital (BCCH) for a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive and be cured by a gene modification treatment known as “Prime Editing.”
Born and raised in Johannesburg, Dr. Alastair McAlpine, a researcher with the Vaccine Evaluation Center (VEC) at BC Children’s Hospital Research Institute (BCCHR), is passionate about pediatric palliative care and infectious diseases. He received his medical training in South Africa, but limited vacancies to pursue a specialization in his desired field brought him to Vancouver. After meeting a…
Dr. Matthew Wiens and colleagues at the Institute for Global Health at BC Children’s & Women’s Hospital, BC Children’s Research Institute, and the University of British Columbia, are the first Canadian Team to lead a Horizon Europe Pillar 2 project. The consortium was recently awarded €5 million under the Global Health EDCTP3 Joint Undertaking for a project that…
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.